Mariola Fotin-Mleczek
Chief Tech/Sci/R&D Officer bei CureVac SE
Profil
Dr. Mariola Fotin-Mleczek ist Chief Technology Officer bei der CureVac AG und Chief Technology Officer bei CureVac NV.
Aktive Positionen von Mariola Fotin-Mleczek
| Unternehmen | Position | Beginn |
|---|---|---|
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Chief Tech/Sci/R&D Officer | 01.01.2013 |
Ehemalige bekannte Positionen von Mariola Fotin-Mleczek
| Unternehmen | Position | Ende |
|---|---|---|
| CUREVAC N.V. | Chief Tech/Sci/R&D Officer | 31.01.2022 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CUREVAC N.V. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
